Shareholder Alert: Robbins LLP is Investigating the Officers and Directors of ECMOHO Ltd. (MOHO) on Behalf of Shareholders July 21, 2020 (San Diego, CA & Shanghai, China) – Shareholder rights

Chembio Diagnostics, Inc. (CEMI) Accused of Misleading Shareholders  In March 2020, Chembio entered into a strategic partnership to begin the development of a diagnostic test for the detection of the

Healthcare Services Group, Inc. (HCSG) Fails to Disclose SEC Investigation In March 2017, Monocle Accounting Research issued a report that revealed Healthcare Services had manipulated its reported earnings per share

Verrica Pharmaceuticals Inc. (VRCA) Accused of Misleading Shareholders    On September 16, 2019, Verrica announced it had submitted its New Drug Application (“NDA”) for VP-102 with the U.S. Food &

Exela Technologies Inc. (XELA) Accused of Misleading Shareholders    In Exela’s 2017 and 2018 annual reports and in its first through third quarter 2019 reports, the Company attested to its

Shareholder Alert: Robbins LLP is Investigating the Officers and Directors of Fifth Third Bancorp (FITB) on Behalf of Shareholders July 13, 2020 (San Diego, CA & Cincinnati, OH) – Shareholder

Enphase Energy, Inc. (ENPH) Accused of Misleading Shareholders  On March 15, 2019, Enphase filed its 2018 annual report touting revenue of $316.159 million and gross margins of 29.9%. As the

J2 Global, Inc. (JCOM) Accused of Misleading Shareholders    Throughout the relevant period, J2 Global affirmed that it had disclosed all of its related-party transactions as required by the SEC

CURO Group Holdings, Corp. (CURO) Faces Liability for Misleading Shareholders About FY 2018 Guidance According to the class action complaint filed against CURO Group Holdings, Corp., although CURO was accelerating